Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

November 30, 2027

Study Completion Date

December 31, 2027

Conditions
Coronary Artery Disease
Interventions
DEVICE

Liquid Biopsy System (LBS)

Coronary artery catheter designed to mix intra-arterial flow and simultaneously extract multiple blood samples from around the site of coronary disease within a vessel of interest.

Trial Locations (4)

Unknown

Royal Bournemouth Hospital, Bournemouth

Bristol Heart Institute, Bristol

Royal Papworth Hospital, Cambridge

Norfolk and Norwich Hospital, Norwich

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Royal Papworth Hospital

OTHER_GOV

lead

PlaqueTec Ltd

INDUSTRY

NCT06259019 - Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease | Biotech Hunter | Biotech Hunter